http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0114369-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63a722300d346ffc9fa3b539cc4c37cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2b9dc89cc4ba060cc73bbf0c90bbb78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50476c050033c07d89a2e56dc34968c3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
filingDate 2000-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68c61c4b5bc1cb66c2bbdb6f8965eeb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8446a4228d95a6eca161583bf8483b3
publicationDate 2001-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0114369-A2
titleOfInvention Process for the preparation of paroxetin.hcl
abstract Paroxetine hydrochloride is prepared by subjecting (-)-trans-1-benzyl-4-(4-fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl) piperidine hydrochloride to catalytic hydrogenation in the presence of a noble metal catalyst in a solvent system consisting of either a mixture of propan-2-o1 and a co-solvent, such as acetic acid, or a solvent other than propan-2-o1, preferably ethanol or methanol, optionally with a co-solvent such as water or acetic acid. Use of this solvent system reduces the amount of residual starting material in the paroxetine hydrochloride product.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2005000810-A1
priorityDate 1999-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9801424-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9953865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453835707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20607567
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57144289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233544442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9843029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70030311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127404616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127407860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136014265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422195539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18763690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232877845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232877848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID43815
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15890018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226511707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62878

Total number of triples: 51.